Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Tissue-Specific Immunoregulation: A Call for Better Understanding of the "Immunostat" in the Context of Cancer.

Pao W, Ooi CH, Birzele F, Ruefli-Brasse A, Cannarile MA, Reis B, Scharf SH, Schubert DA, Hatje K, Pelletier N, Spleiss O, Reed JC.

Cancer Discov. 2018 Apr;8(4):395-402. doi: 10.1158/2159-8290.CD-17-1320. Epub 2018 Mar 15. Review.

2.

Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.

Carrillo-Roa T, Labermaier C, Weber P, Herzog DP, Lareau C, Santarelli S, Wagner KV, Rex-Haffner M, Harbich D, Scharf SH, Nemeroff CB, Dunlop BW, Craighead WE, Mayberg HS, Schmidt MV, Uhr M, Holsboer F, Sillaber I, Binder EB, Müller MB.

PLoS Biol. 2017 Dec 28;15(12):e2002690. doi: 10.1371/journal.pbio.2002690. eCollection 2017 Dec.

3.

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S.

Nat Rev Drug Discov. 2018 Apr;17(4):280-299. doi: 10.1038/nrd.2017.221. Epub 2017 Dec 8. Review.

PMID:
29217836
4.

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.

Lindemann L, Porter RH, Scharf SH, Kuennecke B, Bruns A, von Kienlin M, Harrison AC, Paehler A, Funk C, Gloge A, Schneider M, Parrott NJ, Polonchuk L, Niederhauser U, Morairty SR, Kilduff TS, Vieira E, Kolczewski S, Wichmann J, Hartung T, Honer M, Borroni E, Moreau JL, Prinssen E, Spooren W, Wettstein JG, Jaeschke G.

J Pharmacol Exp Ther. 2015 Apr;353(1):213-33. doi: 10.1124/jpet.114.222463. Epub 2015 Feb 9.

PMID:
25665805
5.

Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome.

Scharf SH, Jaeschke G, Wettstein JG, Lindemann L.

Curr Opin Pharmacol. 2015 Feb;20:124-34. doi: 10.1016/j.coph.2014.11.004. Epub 2014 Dec 2. Review.

PMID:
25488569
6.

The stress-inducible actin-interacting protein DRR1 shapes social behavior.

Masana M, Su YA, Liebl C, Wang XD, Jansen L, Westerholz S, Wagner KV, Labermaier C, Scharf SH, Santarelli S, Hartmann J, Schmidt MV, Rein T, Müller MB.

Psychoneuroendocrinology. 2014 Oct;48:98-110. doi: 10.1016/j.psyneuen.2014.06.009. Epub 2014 Jun 19.

PMID:
24998413
7.

A polymorphism in the Crhr1 gene determines stress vulnerability in male mice.

Labermaier C, Kohl C, Hartmann J, Devigny C, Altmann A, Weber P, Arloth J, Quast C, Wagner KV, Scharf SH, Czibere L, Widner-Andrä R, Brenndörfer J, Landgraf R, Hausch F, Jones KA, Müller MB, Uhr M, Holsboer F, Binder EB, Schmidt MV.

Endocrinology. 2014 Jul;155(7):2500-10. doi: 10.1210/en.2013-1986. Epub 2014 Apr 28.

PMID:
24773341
8.

Evidence supporting the match/mismatch hypothesis of psychiatric disorders.

Santarelli S, Lesuis SL, Wang XD, Wagner KV, Hartmann J, Labermaier C, Scharf SH, Müller MB, Holsboer F, Schmidt MV.

Eur Neuropsychopharmacol. 2014 Jun;24(6):907-18. doi: 10.1016/j.euroneuro.2014.02.002. Epub 2014 Feb 15.

PMID:
24589292
9.

Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss.

Wang XD, Su YA, Wagner KV, Avrabos C, Scharf SH, Hartmann J, Wolf M, Liebl C, Kühne C, Wurst W, Holsboer F, Eder M, Deussing JM, Müller MB, Schmidt MV.

Nat Neurosci. 2013 Jun;16(6):706-13. doi: 10.1038/nn.3395. Epub 2013 May 5.

PMID:
23644483
10.

Chronic social stress during adolescence: interplay of paroxetine treatment and ageing.

Scharf SH, Sterlemann V, Liebl C, Müller MB, Schmidt MV.

Neuropharmacology. 2013 Sep;72:38-46. doi: 10.1016/j.neuropharm.2013.03.035. Epub 2013 Apr 16.

PMID:
23602985
11.

Differences in FKBP51 regulation following chronic social defeat stress correlate with individual stress sensitivity: influence of paroxetine treatment.

Wagner KV, Marinescu D, Hartmann J, Wang XD, Labermaier C, Scharf SH, Liebl C, Uhr M, Holsboer F, Müller MB, Schmidt MV.

Neuropsychopharmacology. 2012 Dec;37(13):2797-808. doi: 10.1038/npp.2012.150. Epub 2012 Aug 8.

12.

Fkbp52 heterozygosity alters behavioral, endocrine and neurogenetic parameters under basal and chronic stress conditions in mice.

Hartmann J, Wagner KV, Dedic N, Marinescu D, Scharf SH, Wang XD, Deussing JM, Hausch F, Rein T, Schmidt U, Holsboer F, Müller MB, Schmidt MV.

Psychoneuroendocrinology. 2012 Dec;37(12):2009-21. doi: 10.1016/j.psyneuen.2012.04.017. Epub 2012 May 27.

PMID:
22641006
13.

Animal models of stress vulnerability and resilience in translational research.

Scharf SH, Schmidt MV.

Curr Psychiatry Rep. 2012 Apr;14(2):159-65. doi: 10.1007/s11920-012-0256-0. Review.

PMID:
22278810
14.

Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition.

Schmidt MV, Schülke JP, Liebl C, Stiess M, Avrabos C, Bock J, Wochnik GM, Davies HA, Zimmermann N, Scharf SH, Trümbach D, Wurst W, Zieglgänsberger W, Turck C, Holsboer F, Stewart MG, Bradke F, Eder M, Müller MB, Rein T.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17213-8. doi: 10.1073/pnas.1103318108. Epub 2011 Oct 3.

15.

Forebrain CRF₁ modulates early-life stress-programmed cognitive deficits.

Wang XD, Rammes G, Kraev I, Wolf M, Liebl C, Scharf SH, Rice CJ, Wurst W, Holsboer F, Deussing JM, Baram TZ, Stewart MG, Müller MB, Schmidt MV.

J Neurosci. 2011 Sep 21;31(38):13625-34. doi: 10.1523/JNEUROSCI.2259-11.2011.

16.

The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress.

Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, Wolf M, Hausch F, Rein T, Schmidt U, Touma C, Cheung-Flynn J, Cox MB, Smith DF, Holsboer F, Müller MB, Schmidt MV.

Neuropharmacology. 2012 Jan;62(1):332-9. doi: 10.1016/j.neuropharm.2011.07.041. Epub 2011 Aug 4.

PMID:
21839098
17.

Expression and regulation of the Fkbp5 gene in the adult mouse brain.

Scharf SH, Liebl C, Binder EB, Schmidt MV, Müller MB.

PLoS One. 2011 Feb 9;6(2):e16883. doi: 10.1371/journal.pone.0016883.

18.

Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling.

Wang XD, Chen Y, Wolf M, Wagner KV, Liebl C, Scharf SH, Harbich D, Mayer B, Wurst W, Holsboer F, Deussing JM, Baram TZ, Müller MB, Schmidt MV.

Neurobiol Dis. 2011 Jun;42(3):300-10. doi: 10.1016/j.nbd.2011.01.020. Epub 2011 Feb 3.

19.

Individual stress vulnerability is predicted by short-term memory and AMPA receptor subunit ratio in the hippocampus.

Schmidt MV, Trümbach D, Weber P, Wagner K, Scharf SH, Liebl C, Datson N, Namendorf C, Gerlach T, Kühne C, Uhr M, Deussing JM, Wurst W, Binder EB, Holsboer F, Müller MB.

J Neurosci. 2010 Dec 15;30(50):16949-58. doi: 10.1523/JNEUROSCI.4668-10.2010.

20.

Pituitary glucocorticoid receptor deletion reduces vulnerability to chronic stress.

Wagner KV, Wang XD, Liebl C, Scharf SH, Müller MB, Schmidt MV.

Psychoneuroendocrinology. 2011 May;36(4):579-87. doi: 10.1016/j.psyneuen.2010.09.007.

PMID:
20940090
21.

A novel chronic social stress paradigm in female mice.

Schmidt MV, Scharf SH, Liebl C, Harbich D, Mayer B, Holsboer F, Müller MB.

Horm Behav. 2010 Apr;57(4-5):415-20. doi: 10.1016/j.yhbeh.2010.01.010. Epub 2010 Jan 25.

PMID:
20100488
22.

High susceptibility to chronic social stress is associated with a depression-like phenotype.

Schmidt MV, Scharf SH, Sterlemann V, Ganea K, Liebl C, Holsboer F, Müller MB.

Psychoneuroendocrinology. 2010 Jun;35(5):635-43. doi: 10.1016/j.psyneuen.2009.10.002. Epub 2009 Oct 25.

PMID:
19857931

Supplemental Content

Loading ...
Support Center